EVOTEC SE |
Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
| 6,313 EUR | +1,25 % |
|
+5,78 % | -70,35 % |
| 05/09 | Evotec y X-Chem colaborarán en el descubrimiento de fármacos en fase inicial | MT |
| 05/09 | Evotec SE y X-Chem Inc. colaboran para acelerar el descubrimiento de fármacos en fase inicial | CI |
Grupo Evotec SE : Gráfico Relacional
Empresas privadas pertenecientes al mismo grupo que EVOTEC SE
| Empresa | Director |
|---|---|
Evotec (France) SAS
 Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (France) SAS is a French company that engages in research and development of physical and natural sciences. The company is based in Toulouse, France. The company was founded in 2014. Pierre Cooremans has been the CEO of the company since 2019. | Pierre Cooremans |
Evotec (UK) Ltd.
 Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The company is based in Abingdon, UK and was founded in 1991. | - |
Evotec International GmbH
 Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Evotec International GmbH develops and provides drugs for the treatment of CNS disorders. It focuses on Alzheimer's disease and other neurological disorders. The company was founded in 1999 and is headquartered in Hamburg, Germany. | Matthias Evers |
Aptuit (Verona) Srl
 Aptuit (Verona) Srl Pharmaceuticals: MajorHealth Technology Aptuit (Verona) Srl engages in the provision of integrated drug development solutions. It offers Indigo and Indigo-Select. The company was founded in 2004 and is headquartered in Verona, Italy. | Ciriaco Maraschiello |
MarketScreener is also available in this country: United States.
Switch edition